Ramesh Kumar*
Department of Pharmacy Practice, Sri Ramachandra Institute of Higher Education and Research, Chennai
Received: 01-Mar-2025, Manuscript No. jhcp-25-169367; Editor assigned: 4-Mar-2025, Pre-QC No. jhcp-25-169367 (PQ); Reviewed: 20-Mar-2025, QC No jhcp-25-169367; Revised: 26-Mar-2025, Manuscript No. jhcp-25-169367 (R); Published: 30-Mar-2025, DOI: 10.4172/2320- 7949.11.004
Citation: Ramesh Kumar, Pharmacovigilance and Adverse Drug Reaction Monitoring. RRJ Hosp Clin Pharm. 2025.11.004.
Copyright: © 2025 Ramesh Kumar, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Research & Reviews: Journal of Hospital and Clinical Pharmacy
Pharmacovigilance is integral to patient safety, particularly in resource-limited healthcare settings. In India, the role of clinical pharmacists in ADR monitoring is increasingly recognized. This article emphasizes the significance of their involvement in pharmacovigilance systems.
Active Monitoring and Reporting of ADRs
Clinical pharmacists detect ADRs through patient interviews, chart reviews, and direct observation. A Chennai hospital study showed a 3-fold increase in ADR reporting post pharmacist inclusion [1]. They categorize reactions, report them to the PvPI, and recommend safer alternatives [2].
Training sessions by pharmacists improve healthcare professionals' ability to recognize and report ADRs [3]. They also maintain ADR registries and periodically audit high-risk medications [4]. Regular feedback mechanisms and ADR bulletin dissemination further institutionalize pharmacovigilance practices [5].
Menu